In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE BioDelivery Sciences International, Inc.
This biopharma company's Relistor drug should send revenues sharply higher this year.
This biopharma company's Relistor drug should send revenues sharply higher next year.
There are more dogs on the S&P 500 than on the Dow. Here's one example.
Small-caps could also benefit from abating tax-loss selling.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.